PDSB News and Press, PDS Biotechnology Corporation From 01/31/21

Are These Biotech Names On Your List Of Penny Stocks Right Now? Are you looking for penny stocks to buy right now? If you are, you’re not alone. These cheap stocks have attracted the masses recently, and for a good reason. The strength of retail trading groups has become a cl...

FLORHAM PARK, N.J., Jan. 14, 2021 (GLOBE NEWSWIRE) -- PDS Biotechnology Corporation (Nasdaq: PDSB), a clinical-stage immunotherapy company developing novel cancer therapies and infectious disease vaccines based on the Company’s proprietary Versamune® T-cell activating technology...

PDS Biotechnology (PDSB) has announced an inducement grant of ~202k stock options to Seth Van Voorhees, its newly appointed CFO, vesting over four years with one-quarter of the shares vesting on the first anniversary of the grant date and then monthly over the following 36 mont...

FLORHAM PARK, N.J., Jan. 06, 2021 (GLOBE NEWSWIRE) -- PDS Biotechnology Corporation (Nasdaq: PDSB), a clinical-stage immunotherapy company developing novel cancer therapies and infectious disease vaccines based on the Company’s proprietary Versamune ® T-cell activating techn...

FLORHAM PARK, N.J., Jan. 05, 2021 (GLOBE NEWSWIRE) -- PDS Biotechnology Corporation (Nasdaq: PDSB), a clinical-stage immunotherapy company developing novel cancer therapies and infectious disease vaccines based on the Company’s proprietary Versamune® T-cell activating technology...

FLORHAM PARK, N.J., Dec. 21, 2020 (GLOBE NEWSWIRE) -- PDS Biotechnology Corporation (Nasdaq: PDSB), a clinical-stage immunotherapy company developing novel cancer therapies and infectious disease vaccines based on the Company’s proprietary Versamune® T-cell activating technology...

PDS Biotechnology (PDSB) appointed Dr. Seth Van Voorhees, Ph.D. as its new Chief Financial Officer effective January 1, 2021 to replace Michael King as interim CFO.Dr. Van Voorhees most recently served as the CFO of Research Frontiers (REFR) and for American Pacific.Shares are&...

FLORHAM PARK, N.J., Dec. 09, 2020 (GLOBE NEWSWIRE) -- PDS Biotechnology Corporation (Nasdaq: PDSB), a clinical-stage immunotherapy company developing novel cancer therapies and infectious disease vaccines based on the Company’s proprietary Versamune ® T-cell activating techn...

Why Are Investors Paying Attention to These 5 Penny Stocks? As we enter the second week of December, there are several penny stocks that investors are watching. While unemployment numbers are rising alongside covid cases in the U.S., the long term prospects for the end of the year a...

Gainers: Sutro Biopharma (STRO) +33%, Merrimack Pharmaceuticals (MACK) +18%, Evogene (EVGN) +18%, BioCryst Pharmaceuticals (BCRX) +16%, PDS Biotechnology (PDSB) +15%.Losers: Precision BioSciences DTIL -21%, Cortexyme CRTX -17%, Chembio Di...